Agilon Health Q3 EPS Forecast Lowered by Leerink Partnrs

Key Points

• Leerink Partners has revised its earnings estimates for Agilon Health, predicting a Q3 2025 EPS of ($0.18), down from a previous forecast of ($0.11).
• Agilon Health reported a Q2 loss of ($0.25) EPS, significantly missing the consensus estimate of ($0.11), while also experiencing a revenue decline of 5.9% year-over-year.
• The stock has received a mix of ratings from analysts, with two sell ratings, eleven hold ratings, and five buy ratings, leading to a consensus target price of $4.07.

Agilon Health, Inc. (NYSE:AGL - Free Report) - Equities researchers at Leerink Partnrs dropped their Q3 2025 EPS estimates for shares of Agilon Health in a note issued to investors on Monday, August 4th. Leerink Partnrs analyst W. Mayo now forecasts that the company will earn ($0.18) per share for the quarter, down from their prior forecast of ($0.11). The consensus estimate for Agilon Health's current full-year earnings is ($0.59) per share. Leerink Partnrs also issued estimates for Agilon Health's Q4 2025 earnings at ($0.27) EPS, FY2025 earnings at ($0.70) EPS, Q2 2026 earnings at ($0.16) EPS, Q3 2026 earnings at ($0.11) EPS, Q4 2026 earnings at ($0.12) EPS, FY2026 earnings at ($0.38) EPS, FY2027 earnings at ($0.40) EPS, FY2028 earnings at ($0.34) EPS and FY2029 earnings at ($0.18) EPS.

Several other brokerages also recently commented on AGL. Wells Fargo & Company cut their price objective on shares of Agilon Health from $6.00 to $5.00 and set an "overweight" rating on the stock in a research report on Tuesday, May 13th. TD Cowen increased their price objective on shares of Agilon Health from $3.50 to $6.00 and gave the company a "hold" rating in a research report on Tuesday, April 15th. Evercore ISI dropped their price target on shares of Agilon Health from $5.00 to $3.00 and set an "in-line" rating on the stock in a report on Wednesday, July 9th. Citigroup upgraded shares of Agilon Health from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $3.25 to $5.00 in a research note on Friday, April 25th. Finally, Cowen reiterated a "hold" rating on shares of Agilon Health in a research note on Tuesday, April 15th. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $4.08.

Agilon Health Price Performance

AGL stock traded down $0.05 during trading on Thursday, hitting $0.83. 6,268,243 shares of the stock traded hands, compared to its average volume of 6,830,850. Agilon Health has a 1 year low of $0.71 and a 1 year high of $6.08. The firm's 50 day moving average is $2.08 and its two-hundred day moving average is $3.14. The stock has a market cap of $342.31 million, a price-to-earnings ratio of -1.07 and a beta of 0.14.

Agilon Health (NYSE:AGL - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.11) by ($0.14). Agilon Health had a negative net margin of 5.35% and a negative return on equity of 66.76%. The firm had revenue of $1.39 billion for the quarter, compared to analysts' expectations of $1.47 billion. During the same period last year, the company posted ($0.07) earnings per share. The business's revenue for the quarter was down 5.9% compared to the same quarter last year.

Institutional Trading of Agilon Health

Large investors have recently added to or reduced their stakes in the business. Humankind Investments LLC bought a new stake in Agilon Health during the fourth quarter valued at approximately $30,000. Raymond James Financial Inc. bought a new stake in Agilon Health during the fourth quarter valued at approximately $33,000. Cerity Partners LLC bought a new position in shares of Agilon Health in the fourth quarter worth approximately $34,000. 111 Capital bought a new position in shares of Agilon Health in the second quarter worth approximately $36,000. Finally, Nisa Investment Advisors LLC boosted its position in shares of Agilon Health by 244.9% in the first quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company's stock worth $41,000 after purchasing an additional 6,783 shares during the period.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.